Jogendran, Rohit
Tandon, Parul
Kroeker, Karen I.
Dieleman, Levinus A.
Huang, Vivian https://orcid.org/0000-0002-4524-9403
Article History
Received: 19 December 2020
Accepted: 10 April 2021
First Online: 3 May 2021
Declarations
:
: Rohit Jogendran and Parul Tandon have no personal conflicts to declare with respect to this particular study. Karen Kroeker has the following conflicts of interest to report: Abbvie: Advisory Committees or Review Panels; Janssen: Advisory Committees or Review Panels; Pfizer: Speaking and Teaching; Takeda: Advisory Committees or Review Panels. Levinus Dieleman has the following conflicts of interest to report: Abbvie: Advisory Committees or Review Panels; Jackson GI: Grant/Research Support; Janssen: Advisory Committees or Review Panels; Pfizer: Grant/Research Support. Vivian Huang has the following conflicts of interest to report: Abbvie: Advisor committees or Review Panels—same for Janssen, Pfizer, Merck, Takeda, Ferring, Roche; Abbvie, Janssen, Ferring, Takeda—speaking and teaching.
: This article does not contain any studies with humans or animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.